These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8649828)

  • 1. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning.
    Chan AM; Takai S; Yamada K; Miki T
    Oncogene; 1996 Mar; 12(6):1259-66. PubMed ID: 8649828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins.
    Chan AM; McGovern ES; Catalano G; Fleming TP; Miki T
    Oncogene; 1994 Apr; 9(4):1057-63. PubMed ID: 8134109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene ect2 is related to regulators of small GTP-binding proteins.
    Miki T; Smith CL; Long JE; Eva A; Fleming TP
    Nature; 1993 Apr; 362(6419):462-5. PubMed ID: 8464478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Bcd, a novel proto-oncogene expressed in B-cells.
    El Rouby S; Newcomb EW
    Oncogene; 1996 Dec; 13(12):2623-30. PubMed ID: 9000136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42.
    Lorenzi MV; Castagnino P; Chen Q; Hori Y; Miki T
    Oncogene; 1999 Aug; 18(33):4742-55. PubMed ID: 10467422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes.
    Schuebel KE; Bustelo XR; Nielsen DA; Song BJ; Barbacid M; Goldman D; Lee IJ
    Oncogene; 1996 Jul; 13(2):363-71. PubMed ID: 8710375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor.
    Whitehead I; Kirk H; Kay R
    Oncogene; 1995 Feb; 10(4):713-21. PubMed ID: 7862449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression cDNA cloning of a serine kinase transforming gene.
    Chan AM; Chedid M; McGovern ES; Popescu NC; Miki T; Aaronson SA
    Oncogene; 1993 May; 8(5):1329-33. PubMed ID: 8479752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological significance of the hst-1 gene.
    Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
    Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
    Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
    Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues.
    Aasheim HC; Pedeutour F; Smeland EB
    Oncogene; 1997 Apr; 14(14):1747-52. PubMed ID: 9135076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
    Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells.
    van Leeuwen FN; van der Kammen RA; Habets GG; Collard JG
    Oncogene; 1995 Dec; 11(11):2215-21. PubMed ID: 8570171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTp11, a novel member of the family of human cancer/testis antigens.
    Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
    Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independently activated dbl oncogenes exhibit similar yet distinct structural alterations.
    Eva A; Vecchio G; Diamond M; Tronick SR; Ron D; Cooper GM; Aaronson SA
    Oncogene; 1987; 1(4):355-60. PubMed ID: 3330779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of survival-related gene, a novel cell survival gene controlling apoptosis and tumorigenesis.
    Yuan ZR; Wang R; Solomon J; Luo X; Sun H; Zhang L; Shi Y
    Cancer Res; 2005 Dec; 65(23):10716-24. PubMed ID: 16322216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.